Markets › United States › NAS › ABIO

ARCA biopharma, Inc.

NAS:ABIOHealthcare

——At close · Market cap —

🔔 Alert▶ Test a strategy

Ratio	FY2019	FY2020	FY2021	FY2022	FY2023	FY2025	Current · undated	Trend	YoY
Return on equity	−72.0%	−20.9%	−37.9%	−23.8%	−14.4%	−22.3%	−22.3%		+0.0 pts
Return on assets	−64.2%	−19.3%	−35.2%	−23.0%	−14.1%	−21.6%	−21.6%		+0.0 pts
Return on capital employed	−76.4%	−20.8%	−37.6%	−23.5%	−19.6%	−25.8%	—		—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×		+0.0%
Debt / assets	0.3%	0.8%	0.7%	0.6%	0.5%	0.4%	—		—
Interest coverage	−830.6×	−1,085.1×	0.0×	−14.6×	0.0×	0.0×	—		—
Current ratio	9.2×	14.3×	15.6×	37.7×	59.0×	22.4×	22.4×		+0.0%
Quick ratio	9.2×	14.3×	15.6×	37.7×	59.0×	22.4×	—		—
Cash ratio	9.0×	14.0×	15.3×	37.5×	58.8×	3.1×	3.1×		+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—		—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—		—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.

ABIO · Ratios · TradingHolo